Contact
searchSearch
HMP Global

Videos

Headshot of Shawn Kwatra, MD, Johns Hopkins Itch Center, on a blue background underneath the PopHealth Perspectives logo.
Videos
Topical JAK Inhibitor Reduces Itch in Patients With Atopic Dermatitis
09/30/2022
Shawn Kwatra, MD, FAAD, director, Johns Hopkins Itch Center, shares findings from a recent analysis of two phase 3 trials which investigated the efficacy and safety of a Janus kinase inhibitor for patients with moderate to severe atopic...
Shawn Kwatra, MD, FAAD, director, Johns Hopkins Itch Center, shares findings from a recent analysis of two phase 3 trials which investigated the efficacy and safety of a Janus kinase inhibitor for patients with moderate to severe atopic...
Shawn Kwatra, MD, FAAD,...
09/30/2022
First Report Managed Care
Headshots of Edmund Pezalla, Adam Kittai, Farrukh Awan, Jeffrey Dunn
Videos
Payer, Clinical Considerations for Treating Patients With Zanubrutinib
09/15/2022
In the second part of this roundtable, Edmund Pezalla, MD, MPH; Adam Kittai, MD; Farrukh Awan, MD; and Jeffrey Dunn, PharmD, MBA, discuss cost and access challenges for treating patients with zanubrutinib.
In the second part of this roundtable, Edmund Pezalla, MD, MPH; Adam Kittai, MD; Farrukh Awan, MD; and Jeffrey Dunn, PharmD, MBA, discuss cost and access challenges for treating patients with zanubrutinib.
In the second part of this...
09/15/2022
First Report Managed Care
Headshots of Edmund Pezalla, Adam Kittai, Farrukh Awan, Jeffrey Dunn
Videos
Second-Generation BTK Inhibitors for CLL: Clinical, Managed Care Perspectives
09/15/2022
In the first part of this roundtable, Edmund Pezalla, MD, MPH; Adam Kittai, MD; Farrukh Awan, MD; and Jeffrey Dunn, PharmD, MBA, discuss how second-generation BTK inhibitors are changing the treatment paradigm and payer considerations in...
In the first part of this roundtable, Edmund Pezalla, MD, MPH; Adam Kittai, MD; Farrukh Awan, MD; and Jeffrey Dunn, PharmD, MBA, discuss how second-generation BTK inhibitors are changing the treatment paradigm and payer considerations in...
In the first part of this...
09/15/2022
First Report Managed Care
Headshot of Meilin Diaz-Paez, University of Miami, on a blue background underneath the PopHealth Perspectives logo.
Videos
Improving Patient Access to Therapies for Chronic Graft vs Host Disease
09/01/2022
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, describes what payers should know about patients...
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, describes what payers should know about patients...
Meilin Diaz-Paez, MSN, APRN,...
09/01/2022
First Report Managed Care
Meilin_Diaz_Paez_University_Miami
Videos
Treatment Options for Patients With Chronic Graft vs Host Disease
09/01/2022
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, walks through available therapies for patients...
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, walks through available therapies for patients...
Meilin Diaz-Paez, MSN, APRN,...
09/01/2022
First Report Managed Care
Headshot of Meilin Diaz-Paez, University of Miami, on a blue background underneath the PopHealth Perspectives logo.
Videos
Understanding Symptom Burden, Disease Severity in Graft vs Host Disease
09/01/2022
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, reviews the symptom burden associated with...
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, reviews the symptom burden associated with...
Meilin Diaz-Paez, MSN, APRN,...
09/01/2022
First Report Managed Care
Headshot of Shawn Kwatra, MD, Johns Hopkins Itch Center, on a blue background underneath the PopHealth Perspectives logo.
Videos
Reviewing Unmet Need, Clinical Priorities for Patients With Atopic Dermatitis
08/31/2022
Shawn Kwatra, MD, FAAD, director, Johns Hopkins Itch Center, identifies unmet need for patients with atopic dermatitis and shares what factors clinicians and patients prioritize when deciding on a treatment option. 
Shawn Kwatra, MD, FAAD, director, Johns Hopkins Itch Center, identifies unmet need for patients with atopic dermatitis and shares what factors clinicians and patients prioritize when deciding on a treatment option. 
Shawn Kwatra, MD, FAAD,...
08/31/2022
First Report Managed Care
Dr
Videos
Next Steps in Vitiligo Therapy
08/01/2022
In this short clip, David Rosmarin, MD, discusses the next steps and what to look for in future trials evaluating ruxolitinib cream for the treatment of vitiligo.
In this short clip, David Rosmarin, MD, discusses the next steps and what to look for in future trials evaluating ruxolitinib cream for the treatment of vitiligo.
In this short clip, David...
08/01/2022
The Dermatologist
Ross Summer, MD
Video Series
Navigating the Burden of Interstitial Lung Disease
07/15/2022
For part 1 of this video series, Ross Summer, MD, professor of medicine, director of interstitial lung disease program, section chief of allergy, pulmonary and critical care medicine at Thomas Jefferson University, explains the incidence of...
For part 1 of this video series, Ross Summer, MD, professor of medicine, director of interstitial lung disease program, section chief of allergy, pulmonary and critical care medicine at Thomas Jefferson University, explains the incidence of...
For part 1 of this video series,...
07/15/2022
First Report Managed Care
Ross Summer, MD
Video Series
Current Treatment, Management Landscape for ILD
07/15/2022
Dr Ross Summer describes the current treatment landscape for interstitial lung disease, as well as shares some insight on landmark clinical trials in part 2 of a video series.
Dr Ross Summer describes the current treatment landscape for interstitial lung disease, as well as shares some insight on landmark clinical trials in part 2 of a video series.
Dr Ross Summer describes the...
07/15/2022
First Report Managed Care
FRMC Volume 21, Issue 4

Current Issue

October/November/December Volume 21, Issue 4, First Report Managed Care
Current Issue
Issue Archive

What's Trending?

News
Use of Mental Telehealth Increases Dramatically Nationwide
05/01/2017
A recent study found that the use of telemedicine visits for rural Medicare beneficiaries with mental health disorders increased by thousands each year. 
A recent study found that the use of telemedicine visits for rural Medicare beneficiaries with mental health disorders increased by thousands each year. 
A recent study found that the...
05/01/2017
First Report Managed Care
News
Genetic Risk Affects First-Line Chemoimmunotherapy Outcomes for CLL/SLL
08/17/2021
“Assessment of cytogenetic/molecular risk status for appropriate treatment is vital to optimize clinical and economic outcomes, especially in the novel agent era,” researchers concluded.
“Assessment of cytogenetic/molecular risk status for appropriate treatment is vital to optimize clinical and economic outcomes, especially in the novel agent era,” researchers concluded.
“Assessment of...
08/17/2021
First Report Managed Care
Combination of Liraglutide and Insulin Degludec
08/15/2013
Chicago—According to a randomized, open-label, phase 3 trial, patients with type 2 diabetes who received a combination of liraglutide and insulin degludec had significant reductions in hemoglobin A1c (HbA1c) levels after 26 weeks compared...
Chicago—According to a randomized, open-label, phase 3 trial, patients with type 2 diabetes who received a combination of liraglutide and insulin degludec had significant reductions in hemoglobin A1c (HbA1c) levels after 26 weeks compared...
Chicago—According to a...
08/15/2013
First Report Managed Care
News
Gilead Says Justice Department Investigating Drug Production
06/13/2011
06/13/2011
First Report Managed Care
News
More Patients Visiting Specialists than Primary Care Docs
05/08/2014
A study conducted by IMS Health found that 51% of physician office visits in 2013 were with specialists, marking the first time specialist visits have surpassed primary care visits. The rates of specialist visits have been on the rise for a...
A study conducted by IMS Health found that 51% of physician office visits in 2013 were with specialists, marking the first time specialist visits have surpassed primary care visits. The rates of specialist visits have been on the rise for a...
A study conducted by IMS Health...
05/08/2014
First Report Managed Care

Video Insights

Hennessy Headshot
Videos
Navigating Biosimilar Integration: Cost Savings, Coverage, and Future Strategies for Payers
12/10/2024
John Hennessy, MBA, discusses the complexities of biosimilar adoption, highlighting potential cost savings, payer strategies, challenges in provider and patient acceptance, regulatory impacts, and the critical need for sustainable market...
John Hennessy, MBA, discusses the complexities of biosimilar adoption, highlighting potential cost savings, payer strategies, challenges in provider and patient acceptance, regulatory impacts, and the critical need for sustainable market...
John Hennessy, MBA, discusses...
12/10/2024
First Report Managed Care
Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use